As well as Ewing's sarcoma, synovial sarcoma is classified as a soft‐tissue sarcoma and is reported to be caused by a chromosomal abnormality, and thus it might be worth evaluating the effect of DHODH inhibitor on synovial sarcoma. This evidence concerns the gene DHODH and soft tissue sarcoma.